Latest Pharma Insights
ASH: InnoCare Upbeat About BCL2 Inhibitor Mesutoclax In MCL
InnoCare talks to Scrip about the plans and potential benefits for its BCL2 inhibitor mesutoclax in mantle cell lymphoma and beyond as it presents new results at ASH, as BeOne’s contender sonrontoclax also moves ahead in the same indication.
Scrip - December 9, 2025
InnoCare talks to Scrip about the plans and potential benefits for its BCL2 inhibitor mesutoclax in mantle cell lymphoma and beyond as it presents new results at ASH, as BeOne’s contender sonrontoclax also moves ahead in the same indication.
Scrip - December 9, 2025
Galway Medtech Incubators Nurture Next-Gen Innovators
Start-up medtech firms in the west of Ireland can benefit from incubator programs at two of the region’s universities, which support innovators across the medical device and digital health industries from concept to multi-employee businesses.
Medtech Insight - December 9, 2025
Start-up medtech firms in the west of Ireland can benefit from incubator programs at two of the region’s universities, which support innovators across the medical device and digital health industries from concept to multi-employee businesses.
Medtech Insight - December 9, 2025
Global Medtech Guidance Tracker: November 2025
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 50 documents have been posted on the tracker since its last update.
Medtech Insight - December 9, 2025
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 50 documents have been posted on the tracker since its last update.
Medtech Insight - December 9, 2025
Freenome Goes Public In $330M SPAC, Shares Early Data For Next-Gen CRC Blood Test
Freenome will combine with Perceptive Capital Solutions Corp in a SPAC deal worth $330m. The goal is to advance Freenome’s blood-based tests for early detection of cancer and, in 2026, launch its advanced colorectal cancer detection test SimpleScreen, currently under FDA review.
Medtech Insight - December 9, 2025
Freenome will combine with Perceptive Capital Solutions Corp in a SPAC deal worth $330m. The goal is to advance Freenome’s blood-based tests for early detection of cancer and, in 2026, launch its advanced colorectal cancer detection test SimpleScreen, currently under FDA review.
Medtech Insight - December 9, 2025
Potential US Exit From USMCA Would Place $10.1Bn Cosmetics Sector At Risk – PCPC
The North American cosmetics sector would face major supply-chain and regulatory risks if USMCA is not renewed, says PCPC, which encouraged the US Trade Representative during a Dec. 5 hearing to keep the agreement and its Cosmetics Annex in place as it prepares its Jan. 2 recommendation to Congress.
HBW Insight - December 9, 2025
The North American cosmetics sector would face major supply-chain and regulatory risks if USMCA is not renewed, says PCPC, which encouraged the US Trade Representative during a Dec. 5 hearing to keep the agreement and its Cosmetics Annex in place as it prepares its Jan. 2 recommendation to Congress.
HBW Insight - December 9, 2025
ASH: InnoCare Upbeat About BCL2 Inhibitor Mesutoclax In MCL
InnoCare talks to Scrip about the plans and potential benefits for its BCL2 inhibitor mesutoclax in mantle cell lymphoma and beyond as it presents new results at ASH, as BeOne’s contender sonrontoclax also moves ahead in the same indication.
Scrip - December 9, 2025
InnoCare talks to Scrip about the plans and potential benefits for its BCL2 inhibitor mesutoclax in mantle cell lymphoma and beyond as it presents new results at ASH, as BeOne’s contender sonrontoclax also moves ahead in the same indication.
Scrip - December 9, 2025
Galway Medtech Incubators Nurture Next-Gen Innovators
Start-up medtech firms in the west of Ireland can benefit from incubator programs at two of the region’s universities, which support innovators across the medical device and digital health industries from concept to multi-employee businesses.
Medtech Insight - December 9, 2025
Start-up medtech firms in the west of Ireland can benefit from incubator programs at two of the region’s universities, which support innovators across the medical device and digital health industries from concept to multi-employee businesses.
Medtech Insight - December 9, 2025
Global Medtech Guidance Tracker: November 2025
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 50 documents have been posted on the tracker since its last update.
Medtech Insight - December 9, 2025
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 50 documents have been posted on the tracker since its last update.
Medtech Insight - December 9, 2025
Freenome Goes Public In $330M SPAC, Shares Early Data For Next-Gen CRC Blood Test
Freenome will combine with Perceptive Capital Solutions Corp in a SPAC deal worth $330m. The goal is to advance Freenome’s blood-based tests for early detection of cancer and, in 2026, launch its advanced colorectal cancer detection test SimpleScreen, currently under FDA review.
Medtech Insight - December 9, 2025
Freenome will combine with Perceptive Capital Solutions Corp in a SPAC deal worth $330m. The goal is to advance Freenome’s blood-based tests for early detection of cancer and, in 2026, launch its advanced colorectal cancer detection test SimpleScreen, currently under FDA review.
Medtech Insight - December 9, 2025
Potential US Exit From USMCA Would Place $10.1Bn Cosmetics Sector At Risk – PCPC
The North American cosmetics sector would face major supply-chain and regulatory risks if USMCA is not renewed, says PCPC, which encouraged the US Trade Representative during a Dec. 5 hearing to keep the agreement and its Cosmetics Annex in place as it prepares its Jan. 2 recommendation to Congress.
HBW Insight - December 9, 2025
The North American cosmetics sector would face major supply-chain and regulatory risks if USMCA is not renewed, says PCPC, which encouraged the US Trade Representative during a Dec. 5 hearing to keep the agreement and its Cosmetics Annex in place as it prepares its Jan. 2 recommendation to Congress.
HBW Insight - December 9, 2025
GDUFA Costs ‘Destroy Economics’ Of Onshoring Generics, Cuban Warns
Cuban argues that user fees under the GDUFA program are deterring domestic production of generics, according to reports.
Generics Bulletin - December 8, 2025
Cuban argues that user fees under the GDUFA program are deterring domestic production of generics, according to reports.
Generics Bulletin - December 8, 2025
Saya-Enze Partnership Signals Growing Momentum For Biosimilars In Mexico
Collaboration aims to bring two biosimilars for osteoporosis and osteoarthritis to Mexico, with Saya leading commercialization and Enzene overseeing development and manufacturing.
Generics Bulletin - December 8, 2025
Collaboration aims to bring two biosimilars for osteoporosis and osteoarthritis to Mexico, with Saya leading commercialization and Enzene overseeing development and manufacturing.
Generics Bulletin - December 8, 2025
David And Goliath: How A Parent-Led Buyers’ Club Challenged Cystic Fibrosis Giant Vertex
After years of fighting and securing treatment for her daughter, cystic fibrosis campaigner Gayle Pledger could not leave other patients behind. This is a story of families coming together and finding a generic drug manufacturer in order to save their children.
Generics Bulletin - December 8, 2025
After years of fighting and securing treatment for her daughter, cystic fibrosis campaigner Gayle Pledger could not leave other patients behind. This is a story of families coming together and finding a generic drug manufacturer in order to save their children.
Generics Bulletin - December 8, 2025
Wherever Medtech Goes, AI Will Have One Hand On The Steering Wheel
The rise and fall of US tariffs and the chill headwind from China’s state procurement policies have blown onto medtech’s radar. But how to monetize AI is the dominant concern up and down the industry.
In Vivo - December 8, 2025
The rise and fall of US tariffs and the chill headwind from China’s state procurement policies have blown onto medtech’s radar. But how to monetize AI is the dominant concern up and down the industry.
In Vivo - December 8, 2025
Biopharma In 2026: From Darwinian Reset To Disciplined Growth
The biopharmaceutical landscape in 2026 will be shaped by rapid technological progress, shifting geographic leadership, a looming patent cliff and a renewed focus on capital efficiency.
In Vivo - December 8, 2025
The biopharmaceutical landscape in 2026 will be shaped by rapid technological progress, shifting geographic leadership, a looming patent cliff and a renewed focus on capital efficiency.
In Vivo - December 8, 2025
As Lilly And Novo Nordisk Grow Their Obesity Empires, What Comes Next?
Beyond the fierce Lilly and Novo Nordisk competition in the weight-management market, other deep-pocketed firms are advancing their novel candidates and seeking a way in through dealmaking.
In Vivo - December 8, 2025
Beyond the fierce Lilly and Novo Nordisk competition in the weight-management market, other deep-pocketed firms are advancing their novel candidates and seeking a way in through dealmaking.
In Vivo - December 8, 2025